Suven Life Sciences get US Patent
Thursday, December 27, 2007Suven Life Sciences has informed us that the company has secured US Patent # 7,297,711.
This is Suven's first product patent granted in USA. The granted claims of the patent include the class of selective serotonin receptor affinity compounds discovered by Suven and are being developed as therapeutic agents.
According to the invention '711 patent disclosure, the compounds are useful in the treatment of neuro-degenarative disorders like alzheimer's parkinson, schizophrenia and huntington's.
Recent Corporate Earnings / Breaking News
- Larsen & Toubro to spin off ready mix concrete bus...
- Indiabulls Financial Services demerger
- Land Bank of MTNL
- Sun TV FM Live in Vijaywada
- ONGC Videsh exploration blocks in Brazil
- Triton Corp recommends stock split
- JCT MOU with Dakshidin Corporation
- Aban Offshore contract with Chevron Offshore
- Satyam Computer Services to set up new center of e...
- Gamma Infoway into IT - systems and network integr...
